20 LATEST RESOURCES (41 INDEXED)
A Retrospective Analysis of Guanfacine for the Pharmacological Management of Delirium · January 2023
Articles
Cureus
Electrophysiological and Clinical Predictors of Methylphenidate, Guanfacine, and Combined Treatment Outcomes in Children with Attention-Deficit/Hyperactivity Disorder · August 2022
Articles
Journal of the American Academy of Child and Adolescent Psychiatry
Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder · July 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Guanfacine for Irritability, Impulsivity, and Agitation in Elderly Patients: A Report of Two Cases · May 2022
Articles
Psychiatry and Clinical Neurosciences Reports
Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder · September 2020
Articles
Journal of Developmental and Behavioral Pediatrics
Efficacy and Safety of Guanfacine Extended-Release in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled Study · April 2020
Abstracts
Journal of Clinical Psychiatry
Guanfacine Extended-Release for Cannabis Use Disorder: A Pilot Feasibility Trial · July 2019
Articles (Manuscripts-Versions)
PubMed Central>American Journal of Drug and Alcohol Abuse
Population Pharmacokinetic and Exposure-Response Analyses of Guanfacine in Japanese Pediatric ADHD Patients · July 2019
Articles
Drug Metabolism and Pharmacokinetics
Guanfacine Monotherapy for ADHD/ASD Comorbid with Tourette Syndrome: A Case Report · March 2019
Articles
Annals of General Psychiatry
Pharmacokinetics and Pharmacodynamics of Immediate Release vs. Extended Release Guanfacine in Adult Daily Smokers · March 2019
Articles (Manuscripts-Versions)
PubMed Central>Journal of Clinical Psychopharmacology
Guanfacine Hydrochloride Extended-Release for the Treatment of Attention Deficit Hyperactivity Disorder in Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · September 2018
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Distinguishing the Efficacy and Sedative Effects of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder · July 2018
Articles
European Neuropsychopharmacology
Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Older Participants: A Randomized Clinical Trial · May 2018
Articles
Neurobiology of Aging
Guanfacine Hydrochloride Extended-Release for Attention Deficit Hyperactivity Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · March 2018
Publications (Guidelines)
Canadian Agency for Drugs and Technologies in Health
Long-Term Safety and Efficacy of Guanfacine Extended Release in Children and Adolescents with ADHD · February 2018
Articles
European Child and Adolescent Psychiatry
Comparative Efficacy and Safety of Attention-Deficit/Hyperactivity Disorder Pharmacotherapies, Including Guanfacine Extended Release: A Mixed Treatment Comparison · March 2017
Articles
European Child and Adolescent Psychiatry
Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial · February 2017
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder · December 2016
Articles
NCBI>Journal of Child and Adolescent Psychopharmacology
Treatment Efficacy of Combined Sertraline and Guanfacine in Comorbid OCD and ADHD: Two Case Studies · July 2016
Articles (Manuscripts-Versions)
PubMed Central>Journal of Developmental and Behavioral Pediatrics